Literature DB >> 12969871

Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells.

Deborah A Lewinsohn1, Amy S Heinzel, James M Gardner, Liqing Zhu, Mark R Alderson, David M Lewinsohn.   

Abstract

Both CD4+ and CD8+ T cells are important for successful immunity to tuberculosis and have redundant effector functions, such as cytolysis and release of potent antimycobacterial cytokines such as interferon-gamma and tumor necrosis factor-alpha. We hypothesized that CD8+ T cells play a unique role in host defense to Mycobacterium tuberculosis infection as well. Possibilities include preferential and/or enhanced release of granular constituents and/or preferential recognition of heavily infected cells. Utilizing human, Mycobacterium tuberculosis-specific, CD4+ and CD8+ T cell clones, we demonstrate that, after recognition of antigen-presenting cells displaying peptide antigen, CD4+ T cells preferentially release interferon-gamma, whereas CD8+ T cells preferentially lyse antigen-presenting cells. Furthermore, utilizing dendritic cells infected with Mycobacterium tuberculosis expressing green fluorescent protein, we show that CD8+ T cells preferentially recognize heavily infected cells that constitute the minority of infected cells. These data support the hypothesis that the central role of CD8+ T cells in the control of infection with Mycobacterium tuberculosis may be that of surveillance; in essence, recognition of cells in which the containment of Mycobacterium tuberculosis is no longer effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969871     DOI: 10.1164/rccm.200306-837OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  59 in total

1.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

2.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 3.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

4.  Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Luke Elizabeth Hanna; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2014-07-01       Impact factor: 3.131

5.  Elevated Pre-Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection.

Authors:  Shruthi Ravimohan; Neo Tamuhla; Kebatshabile Nfanyana; Houping Ni; Andrew P Steenhoff; Robert Gross; Drew Weissman; Gregory P Bisson
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

6.  Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates.

Authors:  Luka Cicin-Sain; Susan Smyk-Pearson; Sue Smyk-Paerson; Noreen Currier; Laura Byrd; Caroline Koudelka; Tammie Robinson; Gwendolyn Swarbrick; Shane Tackitt; Alfred Legasse; Miranda Fischer; Dragana Nikolich-Zugich; Byung Park; Theodore Hobbs; Cynthia J Doane; Motomi Mori; Michael K Axthelm; Michael T Axthelm; Deborah A Lewinsohn; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

7.  Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.

Authors:  Mi Ra Ryu; Min-Seung Park; Eun Hye Cho; Chul Won Jung; Kihyun Kim; Seok Jin Kim; Ha Young Oh; Wooseong Huh; Hye Ryoun Jang; Won-Jung Koh; Hye Yun Park; Young-Ho Kim; Dong Hyun Sinn; Jin-Oh Choi; Jae-Won Joh; Jong Man Kim; Sung Joo Kim; Jae Berm Park; Eun-Suk Kang
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

Review 8.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

9.  Human mucosal associated invariant T cells detect bacterially infected cells.

Authors:  Marielle C Gold; Stefania Cerri; Susan Smyk-Pearson; Meghan E Cansler; Todd M Vogt; Jacob Delepine; Ervina Winata; Gwendolyn M Swarbrick; Wei-Jen Chua; Yik Y L Yu; Olivier Lantz; Matthew S Cook; Megan D Null; David B Jacoby; Melanie J Harriff; Deborah A Lewinsohn; Ted H Hansen; David M Lewinsohn
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

10.  Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis.

Authors:  Riva Kovjazin; David Shitrit; Rachel Preiss; Ilanit Haim; Lev Triezer; Leonardo Fuks; Abdel Rahman Nader; Meir Raz; Ritta Bardenstein; Galit Horn; Nechama I Smorodinsky; Lior Carmon
Journal:  Clin Vaccine Immunol       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.